GoFinsa

Welcome to GoFinsa!

UnitedHealth Group

UNH
394.15 USD
-0.40%
Session close supplied for

US market indices — session close

· US trading-session date · Points, not USD

Dow Jones Industrial Average

51,285.73 points

-237.33 points (-0.46%)

Nasdaq Composite

24,579.42 points

+264.43 points (+1.09%)

S&P 500

7,376.86 points

+23.13 points (+0.31%)

November 6, 2026 session closes reported by Associated Press and corroborated by Reuters; not live. Nasdaq means the Nasdaq Composite.

UnitedHealth Group stock (UNH) price and technical analysis

GoFinsa tracks UnitedHealth Group under symbol UNH, with the latest available price at 394.15 USD. This page includes multi-timeframe charts, technical analysis and related market news.

The session change is -0.4%.

Market data source: Dated supplied session quote · Latest available update: 2026-11-06 · Delayed market data

UnitedHealth Group (UNH) — Session close

· US trading-session date · USD

394.15 USD

Session change
-0.40%
Trading volume
5.9M shares
Relative volume
1.17×

Dated close values supplied for this session; not live prices or independently exchange-verified. K/M/B volume abbreviations preserve the source rounding.

Retained financial reference data

Previous record reference: 2026-10-27. These financial metrics were not recalculated or refreshed with the stock price.

Market capitalization (reference)
374.3 B USD
Trailing P/E (reference)
23.93
Trailing EPS (reference)
17.52 USD
Trailing dividend yield (reference)
2.23%
Sector
الخدمات الصحية
Analyst view (reference)
شراء
Net margin (reference)
—
Return on equity (reference)
—

Retained technical reference data

Previous record reference: 2026-10-27. Not recomputed using the new close.

Technical rating: —RSI (14): —MACD: —CCI: —

UnitedHealth Group (UNH) Stock: Price, Financials and Investment Analysis

Company research · UNH

Investment overview: what makes UnitedHealth Group different?

UnitedHealth Group (UNH) provides public-market exposure to health insurance, managed care and related healthcare services. A familiar corporate name should not be confused with an attractive investment at every price. A careful appraisal separates business quality, balance-sheet resilience, long-term growth and the price being asked for future cash flows. This company is exposed to membership trends, care-delivery productivity and pharmacy-service scale, while operational results can change with customer budgets and industry conditions. This guide focuses on questions investors can verify rather than offering a mechanical buy or sell instruction. Even a high-quality business can disappoint shareholders if its valuation already assumes flawless execution.

Reference stock price, percentage change and volume

The supplied market snapshot associated with October 14, 2026 shows a reference price of $377.76 per share, a reported change of -0.20%, and approximately 12.65M shares in volume. These are dated reference-session figures provided before the U.S. market opened on October 14, not a live quote and not the final October 14 closing price. Extended-hours transactions may occur at different prices and under different liquidity conditions. A single daily move does not prove a fundamental improvement or deterioration. Check the timestamp and market session before comparing the snapshot with later quotes or using it in a decision.

Business model and revenue generation

The operating business is centered on health insurance, managed care and related healthcare services. To understand how durable revenue may be, identify who ultimately pays, how contracts are renewed and how quickly customers can change suppliers. Revenue recognition and cash collection are not identical; deferred revenue, customer advances, inventory and receivables can all change the cash picture. Investors should compare organic activity across consistent reporting periods and distinguish underlying demand from acquired growth, price changes and currency translations. The strength of a business model is best judged across multiple cycles, rather than from one exceptional quarter or a promotional product announcement.

Growth opportunities and demand drivers

Potential growth drivers include membership trends, care-delivery productivity and pharmacy-service scale. These trends matter only insofar as they can produce profitable sales at an acceptable capital cost. A large addressable market is not a company-specific revenue forecast: competition, execution capacity and contract timing all affect the amount that reaches the income statement. Look for evidence of expanding customer adoption, stronger retention, improved unit economics and a repeatable sales process. It is also important to distinguish a signed order from recognized revenue and revenue from free cash flow. Different stages of the same growth project can carry very different execution risks.

Company scale and what market capitalization tells us

The supplied financial profile lists roughly $447.57 billion of fiscal-year revenue, while the market snapshot places equity market capitalization near $339.08 billion. Revenue measures activity over an accounting period; market capitalization reflects the share price multiplied by outstanding shares at a point in time. They are not interchangeable indicators of profitability or intrinsic value. A fuller review includes the earnings margin, cash available after essential investment, debt obligations and potential dilution. These amounts are reference values taken from the supplied material and should be updated against official reports before being presented as current beyond the stated snapshot.

Margins, earnings and cash-flow quality

For UnitedHealth Group, an especially useful operating lens is medical cost ratios and operating cash generation. Accounting income may be affected by restructuring, asset sales, amortization, taxes or other items that do not repeat every period. Free cash flow should be examined after normal operating needs and necessary capital spending, rather than accepted from a headline without reading the reconciliation. Changes in working capital can temporarily support or suppress cash generation. When profit rises but cash conversion weakens for several consecutive periods, the difference deserves investigation. Conversely, heavier investment may be justified if management can demonstrate a credible future return on that capital.

Official financial results from SEC filings

According to official SEC filings, annual revenue was $447.567 billion, net income was $12.056 billion, and operating cash flow was $19.697 billion for the fiscal year ended 2025-12-31. These figures should be assessed alongside margins, capital expenditure and leverage; operating cash flow is not the same as free cash flow.

Competitive position and customer economics

UnitedHealth Group operates in markets where alternative suppliers, evolving technology and the bargaining power of customers can reshape economics. The opportunity around membership trends, care-delivery productivity and pharmacy-service scale is meaningful, but it is not a permanent competitive moat on its own. Review pricing power, customer retention, intellectual property, distribution effectiveness and the costs customers face when switching. Depending on the industry, concentration among employers, members and care providers can either improve operating efficiency or amplify dependency risk. Peer comparisons should control for margins, revenue recognition practices and financial leverage. An apparent valuation discount sometimes reflects a real structural difference rather than an overlooked bargain.

Risk factors that could change the thesis

Material business-specific risks include medical cost pressure, reimbursement rules, policy scrutiny and operational complexity. These sit alongside economy-wide exposure to rates, inflation, financing conditions, exchange rates and sudden revisions to market expectations. It helps to convert each risk into a measurable question: Which event would invalidate the assumed revenue trajectory? How quickly could costs rise? Could a concentrated customer reduce purchases or a regulatory change alter profitability? Volatile stocks can gap through planned exit levels, especially after earnings announcements or unexpected news. A risk section is most useful when it specifies what evidence would cause the investment thesis to be reconsidered.

Valuation: avoid treating one multiple as an answer

There is no objective conclusion about UNH from the share price alone. Valuation requires scenarios for growth, margin sustainability, reinvestment and the cost of capital, with attention to outstanding debt and the number of shares. A price-to-earnings multiple can be distorted by one-time charges, tax effects or a temporary industry peak. Comparing against peers can help, but only after adjusting for business mix, balance-sheet structure and capital intensity. Market expectations matter: excellent results may still disappoint if investors previously priced in even more exceptional performance. Using several scenarios is more defensible than attaching certainty to one target price.

How to read quarterly earnings and management guidance

Start an earnings review with revenue, operating income, margins and cash flow, then study the industry-specific measures represented by medical cost ratios and operating cash generation. Compare year-over-year results as well as sequential changes, and identify whether growth came from price, volume, currency or acquisitions. Management guidance is a conditional estimate, not a guarantee. Also read the footnotes for accounting revisions, exceptional items, debt commitments and share-based compensation. The most important test is whether the new results strengthen the ability to produce sustainable cash over several years. A stock can fall on an earnings beat if forward expectations or cash-flow conversion weaken.

Portfolio construction and position sizing

An investor considering UnitedHealth Group should examine how its drivers overlap with other holdings. Owning multiple companies exposed to the same economic cycle, customer category or technology investment trend can create hidden concentration even when the tickers differ. Position sizing needs to reflect liquidity requirements, financial resilience and the ability to tolerate a steep temporary drawdown. A sensible process distinguishes the decision to purchase a new position from the decision to retain an existing one. Investors should not infer diversification merely from the number of securities in an account, or infer safety from a company being included in major indices.

Price action and trading volume without false precision

Price charts can help identify how market participants react to news, but technical analysis should not replace fundamental due diligence. The supplied snapshot reports volume of 12.65M; volume is more informative when compared with a consistent historical average and the correct trading session. Reliable support and resistance analysis requires a sequence of correctly adjusted market prices, not one quoted number. Pre-market moves may be driven by fewer orders and should not be labeled as regular-session closing prices. This article intentionally does not invent chart levels, trading signals or a price target unsupported by historical data.

Using the GoFinsa stock research page

Treat the GoFinsa profile for UNH as a research starting point rather than an automated recommendation. Check the displayed data timestamp, the market session, the company filings and the timing of upcoming results. Prioritize operating indicators such as medical cost ratios and operating cash generation along with the balance sheet and cash-flow statement. If an article remains online after the quoted snapshot, the historical data must still be described as historical. No single article can determine an individual reader’s circumstances, tolerance for loss or regulatory eligibility. Independent research and, where appropriate, guidance from a licensed professional remain essential.

Bottom line for long-term investors

UnitedHealth Group offers business exposure to health insurance, managed care and related healthcare services. The key opportunities involve membership trends, care-delivery productivity and pharmacy-service scale, while the central uncertainties include medical cost pressure, reimbursement rules, policy scrutiny and operational complexity. An informed investment thesis weighs how those competing forces affect sustainable earnings and cash flows relative to the market price. Readers can improve decisions by documenting a base case, a downside case, and the observable events that would cause them to revise either. The quote, daily change and volume on this page are a dated reference snapshot, not real-time prices. Capital is at risk, and leveraged products can amplify losses significantly.

Frequently asked questions

Q: What was the reference price for UNH? A: The supplied dated snapshot shows $377.76, a -0.20% change, not a live price.

Q: What volume was recorded in the source snapshot? A: The supplied screener shows 12.65M shares in volume.

Q: What should investors watch? A: Key risks include medical cost pressure, reimbursement rules, policy scrutiny and operational complexity; review official earnings and cash flow.

Q: Is UNH available via XTB? A: Instrument availability depends on the country, account type and broker product list; verify directly before trading.

Frequently asked questions about UnitedHealth Group (UNH)

What is the price of UnitedHealth Group (UNH)?

The latest price available in GoFinsa data is 394.15 USD. Price status may be live or delayed depending on the market and data provider.

What does the technical analysis for UnitedHealth Group (UNH) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for UnitedHealth Group?

The GoFinsa.com General Index is currently unavailable for this instrument.